Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

• Bruce J Brew ,

  *To whom correspondence should be addressed. E-mail: B.Brew@.unsw.edu.au

  Affiliation Department of Neurology and Centre for Immunology, National Centre in HIV Epidemiology and Clinical Research, St. Vincent's Hospital, Darlinghurst, Sydney, Australia

  ⨯
• Mark Halman,

  Affiliation Department of Psychiatry, Saint Michael's Hospital, Toronto, Ontario, Canada

  ⨯
• Jose Catalan,

  Affiliation Psychological Medicine Unit, South Kensington and Chelsea Mental Health Centre, Imperial College, London, United Kingdom

  ⨯
• Ned Sacktor,

  Affiliation HIV Neuroscience Group, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Richard W Price,

  Affiliation San Francisco General Hospital, Department of Neurology, San Francisco, California, United States of America

  ⨯
• Steve Brown,

  Affiliation University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Hamp Atkinson,

  Affiliation HIV Neurobehavioral Research Center, San Diego, California, United States of America

  ⨯
• David B Clifford,

  Affiliation Department of Neurology, Neurologic AIDS Research Consortium, Washington University Medical Center, St. Louis, Missouri, United States of America

  ⨯
• David Simpson,

  Affiliation Neurophysiology, Mt. Sinai Medical Center, New York, New York, United States of America

  ⨯
• Gabriel Torres,

  Affiliation

  ⨯
• Colin Hall,

  Affiliation

  ⨯
• Christopher Power,

  Affiliation

  ⨯
• Karen Marder,

  Affiliation

  ⨯
• Justin C. Mc Arthur,

  Affiliation HIV Neuroscience Group, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• William Symonds,

  Affiliation

  ⨯
•  [ ... ],
• Carmen Romero

  Affiliation

  ⨯
• [ view all ]
• [ view less ]